[A case of recurrent breast cancer with multiple lung metastases responding to anastrozole monotherapy].
A 51-year-old postmenopausal woman was referred to our hospital for treatment of ER-positive recurrent breast cancer. The patient had lung and pleural metastases with pleural effusion from breast cancer. She was treated with anastrozole, a 3rd-generation aromatiase inhibitor. The efficacy of the treatment was definite: the multiple metastatic lung lesions showed a partial response after 5 months' treatment, and reached a complete response after 14 months' treatment. The patient experienced no adverse effects with this therapy. Anastrozole therapy is a useful treatment for postmenopausal woman with ER-positive recurrent breast cancer.
Maruyama
Shuichiro
S
Department of Surgery, Himeji St. Mary's Hospital.
Ito
Maiko
M
Hirano
Yutaka
Y
Shimo
Toshiro
T
Hashida
Shinsuke
S
Iga
Korechika
K
Inukai
Michio
M
Kanaya
Yoshiaki
Y
Yokoyama
Nobuji
N
D000077384:Anastrozole; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use*; D011859:Radiography; D014230:Triazoles / Q000627:therapeutic use*
D014408:Biomarkers, Tumor; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole